Published in Int Rev Cytol on January 01, 1982
Papillomavirus capsid binding and uptake by cells from different tissues and species. J Virol (1995) 2.24
Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J Virol (1995) 2.24
Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells. J Virol (1984) 1.81
Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade. J Virol (1986) 1.68
Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation. Biophys J (2004) 1.61
General analysis of receptor-mediated viral attachment to cell surfaces. Biophys J (1990) 1.58
Characterization of saturable binding sites for rabies virus. J Virol (1984) 1.53
Structural similarities between the mammalian beta-adrenergic and reovirus type 3 receptors. Proc Natl Acad Sci U S A (1985) 1.34
Saturable attachment sites for polyhedron-derived baculovirus on insect cells and evidence for entry via direct membrane fusion. J Virol (1993) 1.19
CD46 is a cellular receptor for bovine viral diarrhea virus. J Virol (2004) 1.11
The 32-kilodalton envelope protein of vaccinia virus synthesized in Escherichia coli binds with specificity to cell surfaces. J Virol (1991) 0.99
Cationic liposomes (Lipofectin) mediate retroviral infection in the absence of specific receptors. J Virol (1990) 0.96
Viral multiplicity of attachment and its implications for human immunodeficiency virus therapies. J Virol (1994) 0.95
Evidence that binding of cucumber necrosis virus to vector zoospores involves recognition of oligosaccharides. J Virol (2003) 0.89
Species differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirus. Mol Pharm (2010) 0.86
Selective tropism of a neurotropic coronavirus for ependymal cells, neurons, and meningeal cells. J Virol (1986) 0.83
Adsorption of mycoplasmavirus MV-L2 to Acholeplasma laidlawii: effects of changes in the acyl-chain composition of membrane lipids. J Virol (1986) 0.80
Characterization of I/F1 glycoprotein as a receptor for Mycoplasma pneumoniae. Infect Immun (1992) 0.75
Cell-cell recognition of host surfaces by pathogens. The adsorption of maize (Zea mays) root mucilage by surfaces of pathogenic fungi. Biochem J (1986) 0.75
Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science (1994) 8.69
B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell (1995) 6.88
Time of gene expression in relation to centromere distance during the cell cycle of Saccharomyces cereviseae. Proc Natl Acad Sci U S A (1968) 5.27
Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A (1992) 4.94
T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature (1990) 4.40
Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet (1999) 4.20
Molecular basis of reovirus virulence: role of the S1 gene. Proc Natl Acad Sci U S A (1977) 3.97
Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J Immunol (2001) 3.86
Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature (1995) 3.46
Effects of oral administration of type II collagen on rheumatoid arthritis. Science (1993) 3.32
Absolute linkage of virulence and central nervous system cell tropism of reoviruses to viral hemagglutinin. J Infect Dis (1980) 3.27
Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med (2000) 3.15
CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A (1999) 3.07
IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol (1998) 2.93
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med (1983) 2.93
Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. Science (1990) 2.86
Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci U S A (1994) 2.82
Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci U S A (1991) 2.72
Antigen-driven bystander suppression after oral administration of antigens. J Exp Med (1991) 2.62
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol (1988) 2.59
Seasonal prevalence of MS disease activity. Neurology (2010) 2.59
Neutralization of reovirus: the gene responsible for the neutralization antigen. J Exp Med (1977) 2.53
Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med (1994) 2.45
Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology (1995) 2.42
Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler (1999) 2.35
Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms. Am J Dis Child (1990) 2.30
HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology (2010) 2.29
Identification of the gene coding for the hemagglutinin of reovirus. Virology (1978) 2.28
Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest (1996) 2.27
In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl J Med (1985) 2.27
Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. N Engl J Med (1980) 2.21
Patterns of disclosure and perceptions of the human immunodeficiency virus in infected elementary school-age children. Arch Pediatr Adolesc Med (1997) 2.14
Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol (1990) 2.13
Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J Immunol (1990) 2.09
Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci U S A (1996) 2.06
Surgery for angiographically occult cerebral aneurysms. J Neurosurg (1993) 2.06
Interaction of reovirus with cell surface receptors. I. Murine and human lymphocytes have a receptor for the hemagglutinin of reovirus type 3. J Immunol (1980) 2.06
Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol (1986) 2.06
T-cell recognition of myelin basic protein. Immunol Today (1991) 1.98
Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc Natl Acad Sci U S A (1997) 1.95
A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol (1987) 1.92
Common T-cell receptor V beta usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis. Ann Neurol (1991) 1.85
The neuropathogenesis of HIV-1 infection. J Leukoc Biol (1994) 1.83
CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis. Neurology (2012) 1.80
Induction of partial immune tolerance to factor VIII through prior mucosal exposure to the factor VIII C2 domain. J Thromb Haemost (2006) 1.75
Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells. Neurology (2009) 1.73
Monoclonal antibody identification of a 100-kDa membrane protein in HeLa cells and human spinal cord involved in poliovirus attachment. Proc Natl Acad Sci U S A (1988) 1.73
Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial. Am J Ophthalmol (1997) 1.71
Antigen microarrays identify CNS-produced autoantibodies in RRMS. Neurology (2012) 1.67
Relapse of herpes simplex encephalitis. J Child Neurol (1995) 1.66
Oral tolerance: mechanisms and therapeutic applications. Adv Immunol (1999) 1.65
Identification of a hemagglutinin-specific idiotype associated with reovirus recognition shared by lymphoid and neural cells. J Exp Med (1982) 1.64
Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression. J Immunol (1995) 1.63
The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells. Nat Immunol (2001) 1.63
Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglial cells with the SV40 large T antigen. Neurosci Lett (1995) 1.63
FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J Neurosci (1999) 1.58
MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet (2000) 1.58
Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus. J Immunol (1979) 1.52
Oligoclonal T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis. J Exp Med (1988) 1.52
Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene. Proc Natl Acad Sci U S A (1979) 1.50
Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood (1997) 1.49
Neuroimmunology I: Immunoregulation in neurological disease. Ann Neurol (1982) 1.48
MS: a CNS and systemic autoimmune disease. Immunol Today (1989) 1.47
Predicting short-term disability in multiple sclerosis. Neurology (2007) 1.46
The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain (2008) 1.45
Quantitative follow-up of patients with multiple sclerosis using MRI: reproducibility. J Magn Reson Imaging (1999) 1.44
Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid. Ann Neurol (1989) 1.43
Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol (1999) 1.43
Low-dose zidovudine in children with an human immunodeficiency virus type 1 infection acquired in the perinatal period. Pediatrics (1991) 1.41
IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur J Immunol (1998) 1.41
Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease. Proc Natl Acad Sci U S A (2001) 1.41
QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2. Nat Genet (1999) 1.39
Anti-immunoglobulin stimulation of murine lymphocytes. I. Age dependency of the proliferative response. J Immunol (1976) 1.39
Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody. N Engl J Med (1987) 1.38
Viral receptors on isolated murine and human ependymal cells. Science (1982) 1.37
Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J Clin Invest (1998) 1.36
Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J Clin Invest (2001) 1.36
Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. J Immunol (1999) 1.34
Intrathecal synthesis of different alpha-interferons in patients with various neurological diseases. Acta Neurol Scand (1985) 1.34
Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent. Eur J Immunol (2000) 1.33
Antigen reactive memory T cells are defined by Ta1. J Immunol (1986) 1.33
Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches. Eur J Immunol (2001) 1.33
Immunologic mechanisms and therapy in multiple sclerosis. Immunol Rev (1995) 1.33
Immunohistochemical staining of human brain with monoclonal antibodies that identify lymphocytes, monocytes, and the Ia antigen. J Neuroimmunol (1983) 1.33
Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. Am J Pathol (1995) 1.32
Quantitative follow-up of patients with multiple sclerosis using MRI: technical aspects. J Magn Reson Imaging (1999) 1.30
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide. Cell Immunol (1990) 1.29
Age dependent susceptibility to Reovirus type 3 encephalitis: role of viral and host factors. Ann Neurol (1983) 1.29
Pediatric intramedullary spinal cord tumors: special considerations. J Neurooncol (2000) 1.29
Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol (1993) 1.29
Detection of measles virus RNA in lymphocytes from peripheral-blood and brain perivascular infiltrates of patients with subacute sclerosing panencephalitis. N Engl J Med (1985) 1.29
Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis. J Immunol (1987) 1.27
Constituents of sputum: a simple method. Ann Intern Med (1972) 1.27
Human microglial cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection. Ann Neurol (1991) 1.26